IGC Pharma (IGC) Amortization of Deferred Charges (2010 - 2018)
IGC Pharma (IGC) reported Amortization of Deferred Charges of $18000.0 for Q3 2018, down 42.68% year-over-year from $31400.0 in Q3 2017, and up 115.65% quarter-over-quarter from -$115000.0 in Q1 2018.
IGC Pharma (IGC) Amortization of Deferred Charges (2010 - 2018) Analysis & Trends
IGC Pharma (IGC) has 8 years of Amortization of Deferred Charges data on file, last reported at $18000.0 in Q3 2018.
- Amortization of Deferred Charges for Q3 2018 came in at $18000.0, down 42.68% year-over-year; the trailing twelve-month figure through Mar 2019 was $18000.0 (changed N/A YoY), and the FY2019 annual result was $18000.0, changed N/A from the prior year.
- Amortization of Deferred Charges grew to $18000.0 in Q3 2018 per IGC's latest filing, from -$115000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $63616.0 in Q3 2014 and troughed at -$115000.0 in Q1 2018.
- A 5-year average of $27604.3 and a median of $34650.0 in 2016 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2016 and 2018: Amortization of Deferred Charges jumped 356.95% in 2016, then plunged 545.72% in 2018.
- A 5-year view of Amortization of Deferred Charges shows it stood at $55200.0 in 2014, then plunged by 123.05% to -$12726.0 in 2015, then jumped by 356.95% to $32700.0 in 2016, then surged by 43.73% to $47000.0 in 2017, then plunged by 61.7% to $18000.0 in 2018.
- Business Quant data shows IGC's Amortization of Deferred Charges at $18000.0 in Q3 2018, -$115000.0 in Q1 2018, and $47000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | IGC Pharma | 28.11 Mn | 27.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 18,000.00 |
| Sep 30, 2018 | 18,000.00 |
| Mar 31, 2018 | -115,000.00 |
| Mar 31, 2018 | -115,000.00 |
| Dec 31, 2017 | 47,000.00 |
| Dec 31, 2017 | 47,000.00 |
| Sep 30, 2017 | 31,400.00 |
| Sep 30, 2017 | 31,400.00 |
| Jun 30, 2017 | 36,600.00 |
| Jun 30, 2017 | 36,600.00 |
| Mar 31, 2017 | 25,801.00 |
| Mar 31, 2017 | 25,801.00 |
| Dec 31, 2016 | 32,700.00 |
| Dec 31, 2016 | 32,700.00 |
| Sep 30, 2016 | 40,075.00 |
| Sep 30, 2016 | 40,075.00 |
| Jun 30, 2016 | 31,240.00 |
| Jun 30, 2016 | 31,240.00 |
| Mar 31, 2016 | 19,243.00 |
| Mar 31, 2016 | 19,243.00 |